Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogen replacement therapy in the elderly

A Paganini-Hill1

  • 1Department of Preventive Medicine, University of Southern California School of Medicine Los Angeles, USA.

Zentralblatt Fur Gynakologie
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prior endogenous and exogenous estrogen and incident dementia in the 10th decade of life: The 90+ Study.

Climacteric : the journal of the International Menopause Society·2020
Same author

Subcortical Magnetic Resonance Imaging Changes in a Healthy Elderly Population; Stroke Risk Factors, Ultrasound, and Hemostasis Findings.

Journal of neuroimaging : official journal of the American Society of Neuroimaging·2016
Same author

Association of male circumcision with risk of prostate cancer: a meta-analysis.

Prostate cancer and prostatic diseases·2015
Same author

Estrogen in the treatment and prevention of Alzheimer's disease.

International journal of pharmaceutical compounding·2013
Same author

Prevalence of dementia after age 90: results from the 90+ study.

Neurology·2008
Same author

Change in mandibular trabecular pattern and hip fracture rate in elderly women.

Dento maxillo facial radiology·2005
Same journal

About 150 births naturally after previous Caesarean section.

Zentralblatt fur Gynakologie·2010
Same journal

About lutein cysts found in hydrops foetus et placentae.

Zentralblatt fur Gynakologie·2010
Same journal

The potencies of the burner epithelium, especially a tendency to form serous epitrel, squamous and mucosal epithelium.

Zentralblatt fur Gynakologie·2010
Same journal

Two double birth defects causing obstetric difficulties.

Zentralblatt fur Gynakologie·2010
Same journal

The uterine size and fundus level in the first part of pregnancy.

Zentralblatt fur Gynakologie·2010
Same journal

The crossbar interposition.

Zentralblatt fur Gynakologie·2010
See all related articles

Estrogen replacement therapy (ERT) significantly reduces fracture risk and cardiovascular disease in postmenopausal women. While long-term use may increase cancer risks, benefits like bone protection and reduced mortality generally outweigh these concerns for informed patients.

Area of Science:

  • Gerontology
  • Hormone Therapy
  • Public Health

Background:

  • Postmenopausal women experience decreased estrogen, leading to health risks like osteoporosis and cardiovascular disease.
  • Estrogen replacement therapy (ERT) is a common intervention to mitigate these effects.
  • Long-term studies are crucial for understanding the comprehensive risks and benefits of ERT.

Purpose of the Study:

  • To evaluate the long-term risks and benefits of estrogen replacement therapy (ERT) in a postmenopausal population.
  • To assess ERT's impact on osteoporotic bone loss, fractures, cardiovascular events, and Alzheimer's disease.
  • To compare health outcomes between ERT users and non-users in the Leisure World retirement community.

Main Methods:

  • Longitudinal study evaluating ERT use in a defined population (Leisure World retirement community) since the 1970s.

Related Experiment Videos

  • Analysis of ERT's effects on hip fracture rates, bone density, tooth retention, myocardial infarction, stroke, and Alzheimer's disease incidence.
  • Comparison of cancer risks (endometrial, breast) associated with different durations and doses of ERT.

    • Main Results:

    • ERT significantly reduced hip fractures by approximately 50% and preserved more natural teeth.
    • ERT lowered the risk of fatal/nonfatal cardiovascular events (heart disease, stroke) by 20-40%.
    • ERT use was associated with a reduced risk of Alzheimer's disease, with benefits increasing with duration of use, but also increased endometrial and breast cancer risks with prolonged/high-dose use.

    Conclusions:

    • For postmenopausal women, the benefits of ERT, including fracture prevention, cardiovascular risk reduction, and potential Alzheimer's disease mitigation, generally outweigh the risks of endometrial and breast cancers.
    • Informed patient decision-making regarding ERT is essential, considering individual risk factors and therapeutic goals.
    • Long-term and current ERT use demonstrates the greatest protective effects, though risks associated with prolonged use must be carefully managed.